Literature DB >> 23981010

Implication of ultraviolet light in the etiology of uveal melanoma: A review.

Justin D Mallet1,2, Sébastien P Gendron1,2, Marie-Catherine Drigeard Desgarnier1,2, Patrick J Rochette1,2,3.   

Abstract

Uveal melanoma is the most frequent intraocular cancer and the second most common form of melanoma. It metastasizes in half of the patients and the prognostic is poor. Although ultraviolet (UV) radiation is a proven risk factor for skin melanoma, the role of UV light in the etiology of uveal melanoma is still contradictory. We have compared epidemiological and genetic evidences of the potential role of UV radiation in uveal melanoma with data on cutaneous melanoma. Even though frequently mutated genes in skin melanoma (e.g. BRAF) differ from those found in uveal melanoma (i.e. GNAQ, GNA11), their mutation pattern bears strong similarities. Furthermore, we provide new results showing that RAC1, a gene recently found harboring UV-hallmark mutation in skin melanoma, is also mutated in uveal melanoma. This article aims to review the work done in the last decades to understand the etiology of uveal melanoma and discuss new avenues, which shed some light on the potential role of UV exposure in uveal melanoma.
© 2013 The American Society of Photobiology.

Entities:  

Mesh:

Year:  2013        PMID: 23981010     DOI: 10.1111/php.12161

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  11 in total

Review 1.  Malignant melanoma of sun-protected sites: a review of clinical, histological, and molecular features.

Authors:  Emily A Merkel; Pedram Gerami
Journal:  Lab Invest       Date:  2017-01-16       Impact factor: 5.662

Review 2.  Ultraviolet or blue-filtering intraocular lenses: what is the evidence?

Authors:  S M Downes
Journal:  Eye (Lond)       Date:  2016-01-08       Impact factor: 3.775

Review 3.  Disparities in Uveal Melanoma: Patient Characteristics.

Authors:  Erin E Nichols; Ann Richmond; Anthony B Daniels
Journal:  Semin Ophthalmol       Date:  2016-04-29       Impact factor: 1.975

4.  Mitochondrial DNA copy number in peripheral blood and melanoma risk.

Authors:  Jie Shen; Vancheswaran Gopalakrishnan; Jeffrey E Lee; Shenying Fang; Hua Zhao
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

5.  Risk Factors and Relationship of Cutaneous and Uveal Melanocytic Lesions in Monozygotic and Dizygotic Twin Pairs.

Authors:  Renáta Zsanett Csoma; Edit Tóth-Molnár; Anita Varga; Hajnalka Szabó; Hajnalka Orvos; Lajos Kemény; Judit Oláh
Journal:  PLoS One       Date:  2016-08-03       Impact factor: 3.240

Review 6.  The biology of uveal melanoma.

Authors:  Adriana Amaro; Rosaria Gangemi; Francesca Piaggio; Giovanna Angelini; Gaia Barisione; Silvano Ferrini; Ulrich Pfeffer
Journal:  Cancer Metastasis Rev       Date:  2017-03       Impact factor: 9.264

Review 7.  The Role of Immune Checkpoint Blockade in Uveal Melanoma.

Authors:  Anja Wessely; Theresa Steeb; Michael Erdmann; Lucie Heinzerling; Julio Vera; Max Schlaak; Carola Berking; Markus Vincent Heppt
Journal:  Int J Mol Sci       Date:  2020-01-29       Impact factor: 5.923

8.  The Macro-Autophagy-Related Protein Beclin-1 Immunohistochemical Expression Correlates With Tumor Cell Type and Clinical Behavior of Uveal Melanoma.

Authors:  Giuseppe Broggi; Antonio Ieni; Daniela Russo; Silvia Varricchio; Lidia Puzzo; Andrea Russo; Michele Reibaldi; Antonio Longo; Giovanni Tuccari; Stefania Staibano; Rosario Caltabiano
Journal:  Front Oncol       Date:  2020-11-20       Impact factor: 6.244

Review 9.  Iris Colour and the Risk of Developing Uveal Melanoma.

Authors:  Laurien E Houtzagers; Annemijn P A Wierenga; Aleid A M Ruys; Gregorius P M Luyten; Martine J Jager
Journal:  Int J Mol Sci       Date:  2020-09-28       Impact factor: 5.923

Review 10.  Update on uveal melanoma: Translational research from biology to clinical practice (Review).

Authors:  Miguel A Ortega; Oscar Fraile-Martínez; Natalio García-Honduvilla; Santiago Coca; Melchor Álvarez-Mon; Julia Buján; Miguel A Teus
Journal:  Int J Oncol       Date:  2020-10-22       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.